The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.1532+1G>A

CA273297

166646 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 276a0259-f229-43a5-8219-d7d7ba720039
Approved on: 2022-12-14
Published on: 2022-12-14

HGVS expressions

NM_000018.4:c.1532+1G>A
NM_000018.4(ACADVL):c.1532+1G>A
NC_000017.11:g.7224244G>A
CM000679.2:g.7224244G>A
NC_000017.10:g.7127563G>A
CM000679.1:g.7127563G>A
NC_000017.9:g.7068287G>A
NG_007975.1:g.9411G>A
NG_008391.2:g.807C>T
NG_033038.1:g.15301C>T
ENST00000356839.10:c.1532+1G>A
ENST00000322910.9:c.*1487+1G>A
ENST00000350303.9:c.1466+1G>A
ENST00000356839.9:c.1532+1G>A
ENST00000542255.6:n.390+1G>A
ENST00000543245.6:c.1601+1G>A
ENST00000578319.5:n.27+1G>A
ENST00000578711.1:n.740G>A
ENST00000578809.5:n.28G>A
ENST00000579391.1:n.140+1G>A
ENST00000579425.5:n.648+1G>A
ENST00000579546.1:n.272-77G>A
ENST00000579894.5:n.319+1G>A
ENST00000583074.5:n.154-77G>A
ENST00000583850.5:n.307+1G>A
ENST00000583858.5:n.464-77G>A
ENST00000585203.6:n.723+1G>A
NM_000018.3:c.1532+1G>A
NM_001033859.2:c.1466+1G>A
NM_001270447.1:c.1601+1G>A
NM_001270448.1:c.1304+1G>A
NM_001033859.3:c.1466+1G>A
NM_001270447.2:c.1601+1G>A
NM_001270448.2:c.1304+1G>A
More

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PM2_Supporting PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1532+1G>A variant in ACADVL occurs within the canonical splice donor/acceptor site (+/- 1,2) of intron 15. It is predicted to cause skipping of biologically-relevant-exon 15/20, resulting in a frameshift leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). The highest population minor allele frequency in gnomAD v2.1 is 0.000008801 in the European non-Finnish population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting. (ACADVL VCEP specifications version 1; approved November 8, 2021)
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1 is 0.000008801 in the European non-Finnish population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting).
PVS1
The c.1532+1G>A variant in ACADVL occurs within the canonical splice donor/acceptor site (+/- 1,2) of intron 15. It is predicted to cause skipping of biologically-relevant-exon 15/20, resulting in a frameshift leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.